Akero Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Akero Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akero Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Akero Therapeutics by Bank of New York Mellon
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $5.9M | 207k | 28.69 |
2024-06-30 | $5.9M | 251k | 23.46 |
2024-03-31 | $4.8M | 189k | 25.26 |
2023-12-31 | $4.2M | 178k | 23.35 |
2023-09-30 | $25M | 500k | 50.58 |
2023-06-30 | $7.2M | 154k | 46.69 |
2023-03-31 | $4.7M | 123k | 38.26 |
2022-12-31 | $7.7M | 141k | 54.80 |
2022-09-30 | $3.8M | 113k | 34.02 |
2022-06-30 | $814k | 86k | 9.46 |
2022-03-31 | $1.2M | 82k | 14.18 |
2021-12-31 | $1.7M | 79k | 21.16 |
2021-09-30 | $1.7M | 77k | 22.36 |
2021-06-30 | $1.7M | 70k | 24.80 |
2021-03-31 | $1.6M | 55k | 29.00 |
2020-12-31 | $1.6M | 60k | 25.81 |
2020-09-30 | $2.2M | 71k | 30.81 |
2020-06-30 | $1.0M | 41k | 24.95 |
2020-03-31 | $580k | 28k | 21.10 |
2019-12-31 | $422k | 19k | 22.22 |
2019-09-30 | $251k | 11k | 22.84 |